Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy

Journal of Stroke and Cerebrovascular Diseases

Volumn 20, Issue 2, 2011, Pages 124-130

  Masrur, Shihab ^a   Abdullah, Abdul R ^a   Smith, Eric E ^a   Hidalgo, Renzo ^a   El Ghandour, Ahmed ^a   Rordorf, Guy ^a   Schwamm, Lee H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

ICH; in hospital mortality; thrombolysis; tPA

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; BRAIN METASTASIS; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DRUG SAFETY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MALE; MORTALITY; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; BOSTON; BRAIN ISCHEMIA; CHI-SQUARE DISTRIBUTION; COMORBIDITY; FEMALE; FIBRINOLYTIC AGENTS; HOSPITAL MORTALITY; HUMANS; INTRACRANIAL HEMORRHAGES; LOGISTIC MODELS; MALE; NEOPLASMS; ODDS RATIO; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 79951912520     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2009.10.010     Document Type: Article

References (20)

1. Arboix A. Cerebrovascular disease in the cancer patient. Rev Neurol 2000;31:1250-1252.
2. Navi BB, DeAngelis LM, Segal AZ. Multifocal strokes as the presentation of occult lung cancer. J Neurooncol 2007;85:307-309. (Pubitemid 350142521)
3. Li SH, Chen WH, Tang Y, et al. Incidence of ischemic stroke post-chemotherapy: A retrospective review of 10,963 patients. Clin Neurol Neurosurg 2006;108:150-156. (Pubitemid 43075533)
4. Cestari DM, Weine DM, Panageas KS, et al. Stroke in patients with cancer: Incidence and etiology. Neurology 2004;62:2025-2030. (Pubitemid 38738216)
5. Rogers LR. Cerebrovascular complications in cancer patients. Oncology (Williston Park) 1994;8:23-30. (Pubitemid 24214527)
6. Rogers LR. Cerebrovascular complications in cancer patients. Neurol Clin 2003;21:167-192. (Pubitemid 36172467)
7. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
8. Liu CY, Jain V, Shields AF, et al. Efficacy and safety of reteplase for central venous catheter occlusion in patients with cancer. J Vasc Interv Radiol 2004;15:39-44. (Pubitemid 38113841)
9. LaBresh KA, Reeves MJ, Frankel MR, et al. Hospital treatment of patients with ischemic stroke or transient ischemic attack using the "get with the guidelines" program. Arch Intern Med 2008;168:411-417.
10. Zhang YY, Chan DK, Cordato D, et al. Stroke risk factor, pattern and outcome in patients with cancer. Acta Neurol Scand 2006;114:378-383. (Pubitemid 44690778)
11. Nilsson G, Holmberg L, Garmo H, et al. Increased incidence of stroke in women with breast cancer. Eur J Cancer 2005;41:423-429. (Pubitemid 40187214)
12. Braithwaite RS, Chlebowski RT, Lau J, et al. Meta-analysis of vascular and neoplastic events associated with tamoxifen. J Gen Intern Med 2003;18:937-947. (Pubitemid 37510624)
13. Wall JG, Weiss RB, Norton L, et al. Arterial thrombosis associated with adjuvant chemotherapy for breast carcinoma: A Cancer and Leukemia Group B study. Am J Med 1989;87:501-504. (Pubitemid 19274751)
14. Paszat LF, Mackillop WJ, Groome PA, et al. Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries. J Clin Oncol 1998;16:2625-2631. (Pubitemid 28363025)
15. Haynes JC, Machtay M, Weber RS, et al. Relative risk of stroke in head and neck carcinoma patients treated with external cervical irradiation. Laryngoscope 2002;112:1883-1887.
16. Goldstein LB, Adams R, Alberts MJ, et al. Primary prevention of ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Stroke 2006;37:1583-1633. (Pubitemid 44313592)
17. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-1913. (Pubitemid 35472129)
18. Ovbiagele B, Saver JL. The smoking-thrombolysis paradox and acute ischemic stroke. Neurology 2005;65:293-295. (Pubitemid 41022377)
19. Marler JR, Tilley BC, Lu M, et al. Early stroke treatment associated with better outcome: The NINDS rt-PA Stroke Study. Neurology 2000;55:1649-1655.
20. Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: Pooled analysis of ALANTIA, ECASS, and NINDS rt-PA stroke trials. Lancet 2004;363:768-774.